| Drug Name |
Ethosuximide |
| Drug ID |
BADD_D00846 |
| Description |
An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. |
| Indications and Usage |
For the treatment of petit mal epilepsy. |
| Marketing Status |
approved |
| ATC Code |
N03AD01 |
| DrugBank ID |
DB00593
|
| KEGG ID |
D00539
|
| MeSH ID |
D005013
|
| PubChem ID |
3291
|
| TTD Drug ID |
D0Q4XQ
|
| NDC Product Code |
65655-0001; 0071-2418; 61748-025; 49452-2803; 0121-0670; 17349-0006; 59762-2250; 63629-8005; 59762-2350; 23155-532; 0071-0237; 42806-708; 64380-878; 69452-152; 11014-0047; 51927-3436; 42806-711; 10888-8169 |
| UNII |
5SEH9X1D1D
|
| Synonyms |
Ethosuximide | Ethosuccimid | Ethylmethylsuccimide | Ethymal | Zarontin | Petnidan | Pyknolepsinum | Suksilep | Suxilep | Emeside | Etosuximida Faes | Faes, Etosuximida |
